Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Extraocular Extension Melanoma”

41 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 41 results

Testing effectiveness (Phase 2)Study completedNCT00032045
What this trial is testing

Vaccine Therapy and Monoclonal Antibody Therapy in Treating Patients With Stage IV Melanoma

Who this might be right for
Intraocular MelanomaMelanoma (Skin)
National Cancer Institute (NCI)
Early research (Phase 1)Study completedNCT01005472
What this trial is testing

Temozolomide and Sunitinib Malate in Treating Patients With Stage III or Stage IV Malignant Melanoma

Who this might be right for
Metastatic Melanoma
Jonsson Comprehensive Cancer Center 16
Very early researchEnded earlyNCT01730157
What this trial is testing

Radioembolization and Ipilimumab in Treating Patients With Uveal Melanoma With Liver Metastases

Who this might be right for
Ciliary Body and Choroid Melanoma, Medium/Large SizeCiliary Body and Choroid Melanoma, Small SizeExtraocular Extension Melanoma+5 more
Case Comprehensive Cancer Center 6
Testing effectiveness (Phase 2)Study completedNCT00020475
What this trial is testing

Vaccine Therapy in Treating Patients With Metastatic Melanoma of the Eye

Who this might be right for
Extraocular Extension MelanomaRecurrent Intraocular Melanoma
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT00003802
What this trial is testing

Pyrazoloacridine in Treating Patients With Metastatic Skin or Eye Melanoma

Who this might be right for
Intraocular MelanomaMelanoma (Skin)
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Testing effectiveness (Phase 2)Ended earlyNCT01533948
What this trial is testing

Axitinib in Treating Patients With Melanoma That is Metastatic or Cannot Be Removed by Surgery

Who this might be right for
Extraocular Extension MelanomaMetastatic Intraocular MelanomaRecurrent Intraocular Melanoma+9 more
Roswell Park Cancer Institute 25
Testing effectiveness (Phase 2)Study completedNCT00085306
What this trial is testing

Interferon Beta in Treating Patients With Metastatic Cutaneous Melanoma or Ocular Melanoma

Who this might be right for
Stage IV MelanomaRecurrent Melanoma
Case Comprehensive Cancer Center 21
Testing effectiveness (Phase 2)Ended earlyNCT00482911
What this trial is testing

Lenalidomide, Sunitinib, and Cyclophosphamide in Treating Patients With Stage IV Eye Melanoma

Who this might be right for
Intraocular MelanomaMalignant Conjunctival Neoplasm
National Institutes of Health Clinical Center (CC) 12
Testing effectiveness (Phase 2)Study completedNCT00089206
What this trial is testing

Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed By Surgery

Who this might be right for
Intraocular MelanomaMelanoma (Skin)
University of Virginia 7
Testing effectiveness (Phase 2)Study completedNCT00089063
What this trial is testing

Vaccine Therapy With or Without Sargramostim in Treating Patients Who Have Undergone Surgery for Melanoma

Who this might be right for
Ciliary Body and Choroid Melanoma, Medium/Large SizeExtraocular Extension MelanomaIris Melanoma+6 more
National Cancer Institute (NCI) 40
Testing effectiveness (Phase 2)Study completedNCT00089219
What this trial is testing

Vaccine Therapy in Treating Patients With Stage IIIB, Stage IIIC, or Stage IV Melanoma

Who this might be right for
Intraocular MelanomaMelanoma (Skin)
University of Virginia 39
Early research (Phase 1)Study completedNCT00313508
What this trial is testing

Dendritic Cell Vaccination During Lymphoid Reconstruction

Who this might be right for
Intraocular MelanomaMelanoma (Skin)
H. Lee Moffitt Cancer Center and Research Institute 18
Testing effectiveness (Phase 2)Study completedNCT00334776
What this trial is testing

Vaccine Therapy in Treating Patients With Metastatic Melanoma

Who this might be right for
Intraocular MelanomaMelanoma (Skin)
University of Southern California 6
Early research (Phase 1)Ended earlyNCT00002947
What this trial is testing

Indium In 111 Pentetreotide in Treating Patients With Refractory Cancer

Who this might be right for
Brain and Central Nervous System TumorsChildhood Langerhans Cell HistiocytosisGastrointestinal Carcinoid Tumor+9 more
Yale University 35
Early research (Phase 1)Study completedNCT00025181
What this trial is testing

Monoclonal Antibody and Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma That Has Been Removed During Surgery

Who this might be right for
Intraocular MelanomaMelanoma (Skin)
University of Southern California 19
Testing effectiveness (Phase 2)Study completedNCT00058279
What this trial is testing

Monoclonal Antibody Therapy and Interleukin-2 in Treating Patients With Metastatic Melanoma

Who this might be right for
Intraocular MelanomaMelanoma (Skin)
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT00450255
What this trial is testing

VEGF Trap in Treating Patients With Recurrent Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery

Who this might be right for
Ciliary Body and Choroid Melanoma, Medium/Large SizeExtraocular Extension MelanomaIris Melanoma+5 more
National Cancer Institute (NCI) 41
Testing effectiveness (Phase 2)UnknownNCT00489944
What this trial is testing

Sunitinib, Tamoxifen, and Cisplatin in Treating Patients With High-Risk Ocular Melanoma

Who this might be right for
Intraocular Melanoma
San Diego Pacific Oncology & Hematology Associates 50
Testing effectiveness (Phase 2)Study completedNCT01143402
What this trial is testing

Temozolomide or Selumetinib in Treating Patients With Metastatic Melanoma of the Eye

Who this might be right for
Iris MelanomaMedium/Large Size Posterior Uveal MelanomaOcular Melanoma With Extraocular Extension+3 more
National Cancer Institute (NCI) 120
Early research (Phase 1)Study completedNCT00003022
What this trial is testing

Monoclonal Antibody Therapy in Treating Patients With Leptomeningeal Cancer

Who this might be right for
Brain and Central Nervous System TumorsIntraocular MelanomaLung Cancer+4 more
Memorial Sloan Kettering Cancer Center
Load More Results